Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

LFCR

+ Watchlist+ Portfolio

Lifecore Biomedical, Inc.

Regulated industrySells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$6.39
52-Week Range
$3.63 – $8.98
Market Cap
$242.60M
P/E (TTM)
—
EPS (TTM)
-1.27
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
2.66
Return on Equity
—
Return on Assets
—
Gross Margin
27.49%
Operating Margin
-6.20%
Profit Margin
-66.76%
Current Ratio
3.84
Debt/Equity
—
Total Debt
$162.18M
Free Cash Flow
—
Revenue Growth
-18.60%
Earnings Growth
—
Enterprise Value
$432.87M

Market Snapshot

About

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) specializing in complex sterile injectable pharmaceutical products. The company provides services including formulation development, aseptic fill-finish manufacturing, and commercial production for pharmaceutical and biotechnology companies. Lifecore also produces sodium hyaluronate, a biomaterial used in ophthalmic, orthopedic, and other medical applications.